Discover and develop first-in-class antibacterials

Nosopharm’s mission is to discover and develop novel therapeutic molecules from the bacterial genera Xenorhabdus and Photorhabdus in partnership with biopharmaceutical companies.

The first unmet medical need addressed by Nosopharm is the bacterial multiresistance to antibiotics.